SPOTLIGHT: Auriga beefing up sales force

Specialty pharma Auriga Laboratories has added 100 to its sales force of 228 to better tout its respiratory and dermatological products. And according to its website, it's still recruiting. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.